Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

In an in-vitro study conducted with Benzyl 4-hydroxybenzoate (Synonym: benzyl paraben) using human liver microsomes, the hydrolysis of the paraben occurred more rapidly than in plasma. The hydrolysis rate followed first-order kinetics, thus allowing the determination of hydrolysis rate constants and half-lives. The benzyl paraben had a half-life of 43 min. Benzyl paraben is metabolized to benzylparaben-4 O-glucuronide. This active biotransformation is likely to prevent the accumulation of these molecules in man and thus prevent their possible toxicity.

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential

Additional information

In an in-vitro study conducted with Benzyl 4-hydroxybenzoate (Synonym: benzyl paraben) using human liver microsomes,the hydrolysis of the paraben occurred more rapidly than in plasma. The hydrolysis rate followed first-order kinetics, thus allowing the determination of hydrolysis rate constants and half-lives. The benzyl paraben had a half-life of 43 min. Benzyl paraben is metabolized to benzylparaben-4 O-glucuronide.This active biotransformation is likely to prevent the accumulation of these molecules in man and thus prevent their possible toxicity. The results suggest that these parabens do not accumulate in human tissue.